NCT05188638View on ClinicalTrials.gov

Safety of Ascending Single and Multiple Doses of Nebulised SoftOx Inhalation Solution in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

April 13, 2022

Study Completion Date

April 13, 2022

Conditions

Healthy VolunteersSafety

Interventions

DRUG

SoftOx Inhaled Solution (SIS)

SIS consists of the active compound, hypochlorous acid (HOCl). Concentrations of SIS refer to the concentration of HOCl in parts per million (ppm).

DRUG

Placebo

Sterile isotonic saline

Trial Locations (1)

DK-2400

DanTrials ApS, Copenhagen

All Listed Sponsors

lead

SoftOx Solutions AS

INDUSTRY

NCT05188638 - Safety of Ascending Single and Multiple Doses of Nebulised SoftOx Inhalation Solution in Healthy Subjects | Biotech Hunter | Biotech Hunter